110 related articles for article (PubMed ID: 37005756)
1. MAPK9 is Correlated with a Poor Prognosis and Tumor Progression in Glioma.
Yang X; Jia Q; Liu X; Wu W; Han Y; Zou Z; Li M; Fan D; Song J; Chen L
Front Biosci (Landmark Ed); 2023 Mar; 28(3):63. PubMed ID: 37005756
[TBL] [Abstract][Full Text] [Related]
2. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of lncRNA DANCR positively affects progression of glioma via activating Wnt/β-catenin signaling.
Li J; Zhou L
Biomed Pharmacother; 2018 Jun; 102():602-607. PubMed ID: 29602127
[TBL] [Abstract][Full Text] [Related]
4. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.
Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811
[TBL] [Abstract][Full Text] [Related]
5. HOXB7 promotes proliferation and metastasis of glioma by regulating the Wnt/β-catenin pathway.
Huo XY; Zhang XY; Yuan F; Zhao XY; You BA
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2476-2485. PubMed ID: 30964174
[TBL] [Abstract][Full Text] [Related]
6. MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma.
Tong YQ; Liu B; Zheng HY; Gu J; Liu H; Li F; Tan BH; Hartman M; Song C; Li Y
Oncotarget; 2015 Sep; 6(28):25024-33. PubMed ID: 26317904
[TBL] [Abstract][Full Text] [Related]
7. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway.
Yu X; Wang M; Wu J; Han Q; Zhang X
J Exp Clin Cancer Res; 2019 Jan; 38(1):40. PubMed ID: 30691485
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of ubiquitin-specific protease 2a (USP2a) and nuclear factor erythroid 2-related factor 2 (Nrf2) in human gliomas.
Boustani MR; Khoshnood RJ; Nikpasand F; Taleshi Z; Ahmadi K; Yahaghi E; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():249-52. PubMed ID: 27000259
[TBL] [Abstract][Full Text] [Related]
9. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
[TBL] [Abstract][Full Text] [Related]
10. CircRNF20 aggravates the progression of non-small-cell lung carcinoma by activating MAPK9.
Wang ZX; Zhao Y; Wang YB; Zhang Q; Zou QX; Liang FH; Lin FW
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9981-9989. PubMed ID: 33090403
[TBL] [Abstract][Full Text] [Related]
11. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
[TBL] [Abstract][Full Text] [Related]
12. Methyl-CpG Binding Protein 2 as a Potential Diagnostic and Prognostic Marker Facilitates Glioma Progression Through Activation of Wnt/β-Catenin Pathway.
Huang G; Wu Y; Du Y; Gan H; Hao S
World Neurosurg; 2023 Mar; 171():e560-e571. PubMed ID: 36529430
[TBL] [Abstract][Full Text] [Related]
13. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
Jin T; Li D; Yang T; Liu F; Kong J; Zhou Y
Oncol Rep; 2019 Aug; 42(2):717-725. PubMed ID: 31173266
[TBL] [Abstract][Full Text] [Related]
14. RGS16 promotes glioma progression and serves as a prognostic factor.
Huang R; Li G; Zhao Z; Zeng F; Zhang K; Liu Y; Wang K; Hu H
CNS Neurosci Ther; 2020 Aug; 26(8):791-803. PubMed ID: 32319728
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA LINC01503 predicts worse prognosis in glioma and promotes tumorigenesis and progression through activation of Wnt/β-catenin signaling.
Wang H; Sheng ZG; Dai LZ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1600-1609. PubMed ID: 30840283
[TBL] [Abstract][Full Text] [Related]
16. PLEKHG5 is a novel prognostic biomarker in glioma patients.
Qian M; Chen Z; Wang S; Guo X; Zhang Z; Qiu W; Gao X; Xu J; Zhao R; Xue H; Li G
Int J Clin Oncol; 2019 Nov; 24(11):1350-1358. PubMed ID: 31309383
[TBL] [Abstract][Full Text] [Related]
17. TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
Han MZ; Xu R; Xu YY; Zhang X; Ni SL; Huang B; Chen AJ; Wei YZ; Wang S; Li WJ; Zhang Q; Li G; Li XG; Wang J
J Exp Clin Cancer Res; 2017 Nov; 36(1):155. PubMed ID: 29110682
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑301a/ZNRF3/wnt/β‑catenin signal regulatory crosstalk mediates glioma progression.
Sun J; Ma Q; Shu C; Xiong J; Li B; Wu J; Zhang S; Li J; Liu J; Wang J
Int J Oncol; 2021 Jan; 58(1):45-56. PubMed ID: 33367931
[TBL] [Abstract][Full Text] [Related]
19. Expression of long non-coding RNA MAGI2‑AS3 in human gliomas and its prognostic significance.
Chen XD; Zhu MX; Wang SJ
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3455-3460. PubMed ID: 31081100
[TBL] [Abstract][Full Text] [Related]
20. TUBA1C expression promotes proliferation by regulating the cell cycle and indicates poor prognosis in glioma.
Gui S; Chen P; Liu Y; Chen Q; Cheng T; Lv S; Zhou T; Song Z; Xiao J; He W; Yuan S; Cheng Z
Biochem Biophys Res Commun; 2021 Nov; 577():130-138. PubMed ID: 34517210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
